Anavex Life Sciences Corp (AVXL)

[crescentmotor]

Massaged data can’t hurt us much more than we are already.

Unambiguous successful Rett data is critical. Nuanced data leading to perception of failure could easily result in another stock price loss of over 60% like we saw with the AD data. It would be even more painful than the AD experience potentially leading to a going concern situation for AVXL.

There’s enough here for any pharma to want to pick up the pieces if a complete failure [in AD] happens.

Assuming Rett success, that is true for the new succeeding corporate owner. But I suspect not much value would be left for former AVXL shareholders when AVXL could be liquidated for chump change.